CIK 0001585608
- Non-accelerated filer
- Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-08 | Lizak Carol R. Chief Financial Officer | Grant or award · Stock option (right to buy) | +34,240 | 34,240 | ||
| 2024-10-08 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award | +4,922 | 4,957 | ||
| 2024-10-08 | Chaturvedi Pravin R Chief Scientific Officer | Grant or award · Stock option (right to buy) | +39,376 | 39,376 | ||
| 2024-10-08 | Wolin Jonathan S. See Remarks | Grant or award | +4,922 | 4,955 | ||
| 2024-10-08 | Wolin Jonathan S. See Remarks | Grant or award · Stock option (right to buy) | +39,376 | 39,376 | ||
| 2024-10-08 | CONTE LISA A See Remarks | Grant or award | +16,503 | 16,624 | ||
| 2024-10-08 | CONTE LISA A See Remarks | Grant or award · Stock option (right to buy) | +132,020 | 132,020 | ||
| 2024-10-08 | MICEK JOHN Director | Grant or award · Stock option (right to buy) | +26,500 | 26,500 | ||
| 2024-10-08 | BOCHNOWSKI JAMES J Director | Grant or award · Stock option (right to buy) | +23,200 | 23,200 | ||
| 2024-10-08 | Jayasuriya Anula Director | Grant or award · Stock option (right to buy) | +21,000 | 21,000 | ||
| 2024-10-08 | King Steven R. See Remarks | Grant or award | +4,922 | 4,951 | ||
| 2024-10-08 | King Steven R. See Remarks | Grant or award · Stock option (right to buy) | +39,376 | 39,376 | ||
| 2024-10-08 | Siegel Jonathan B. Director | Grant or award · Stock option (right to buy) | +26,500 | 26,500 | ||
| 2024-05-17 | Chaturvedi Pravin R Chief Scientific Officer | Option exercise | +871 | 2,141 | ||
| 2024-05-17 | Chaturvedi Pravin R Chief Scientific Officer | Option exercise · Restricted stock units | −871 | 871 | ||
| 2024-05-17 | Wolin Jonathan S. Chief of Staff, CCO & GC | Option exercise | +871 | 2,012 | ||
| 2024-05-17 | Wolin Jonathan S. Chief of Staff, CCO & GC | Option exercise · Restricted stock units | −871 | 871 | ||
| 2024-05-17 | Lizak Carol R. Chief Financial Officer | Option exercise | +431 | 1,042 | ||
| 2024-05-17 | Lizak Carol R. Chief Financial Officer | Option exercise · Restricted stock units | −431 | 431 | ||
| 2024-05-17 | King Steven R. See Remarks | Option exercise | +612 | 1,756 |
Page 4 of 10 · 185 trades